Elevated expression of vacuolar proton pump genes and cellular PH in cisplatin resistance.
V-ATPases are proton-translocating enzymes, which are found not only in numerous intracellular organelles but also in the plasma membranes of many eukaryotic cells. Using differential display, we have identified one of the proton pump subunit genes, ATP6C, as a cisplatin-inducible gene. Northern blot analysis demonstrated that expression of other members of the subunit is inducible by cisplatin treatment. Proton pump gene expression is also upregulated in 3 independent cisplatin-resistant cell lines but not in vincristine- or etoposide-resistant cell lines. Cellular pH was significantly higher in cisplatin-resistant cells than in sensitive parental cells. In vitro DNA-binding activity of cisplatin was markedly increased in acidic conditions, suggesting that the cytotoxicity of cisplatin is modulated by cellular pH. Furthermore, the proton pump inhibitor bafilomycin can synergistically potentiate the cytotoxicity of cisplatin but not of etoposide or camptothecin. These results indicate that cellular pH is one of the critical parameters for effective cancer chemotherapy with cisplatin.
Murakami
T
T
Department of Molecular Biology, University of Occupational and Environmental Health, Yahatanishi-ku Kitakyushu, Japan.
Shibuya
I
I
Ise
T
T
Chen
Z S
ZS
Akiyama
S
S
Nakagawa
M
M
Izumi
H
H
Nakamura
T
T
Matsuo
K
K
Yamada
Y
Y
Kohno
K
K
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D015152:Blotting, Northern; D002166:Camptothecin / Q000494:pharmacology; D002945:Cisplatin / Q000494:pharmacology*; D018076:DNA, Complementary / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005047:Etoposide / Q000494:pharmacology; D020869:Gene Expression Profiling; D006801:Humans; D006863:Hydrogen-Ion Concentration; D018942:Macrolides; D017494:Proton Pumps / Q000096:biosynthesis*; D011522:Protons; D013997:Time Factors; D014407:Tumor Cells, Cultured; D015854:Up-Regulation; D014617:Vacuoles / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D018076:DNA, Complementary; D004791:Enzyme Inhibitors; D018942:Macrolides; D017494:Proton Pumps; D011522:Protons; C057620:bafilomycin A; D005047:Etoposide; D002945:Cisplatin; D002166:Camptothecin